Tufts spin-off with an IRB-approved ingestible capsule that samples small-intestine microbiome and contents non-invasively.
Tufts ingestible gut-sampling capsule validated in animals with IRB approval: high-risk biomedical innovation ideal for SBIR Phase I/II.
Evidence from the records
- “Ingestible small intestine sampling capsule”
- “Capsule validated in 3 large animal models”
- Intro path
- G-Space founder (NSF grantee).
- First step
- Submit an NSF SBIR Project Pitch.